文献速递流行病学与生物统计临床试验与 GCP

ICU谵妄随机试验设计与分析异质性:一项系统综述

Heterogeneity in design and analysis of ICU delirium randomized trials: a systematic review.
PubMed 文献 · Trials · 2021-05-20

该系统综述检索了PubMed和Embase,纳入65项以成人ICU患者谵妄为主要结局的随机对照试验,评估谵妄评估频率、结局定义和统计方法的异质性。结果显示多数试验随访≤7天,谵妄发生率最常用两样本比例检验,但未考虑ICU出院或死亡的删失;作者建议明确结局定义并考虑生存分析方法。

要点

  • 65项RCT中44项(68%)针对谵妄预防,31项(48%)随访≤7天。
  • 谵妄发生率最常用两样本比例检验,但未处理ICU出院或死亡删失。
  • 建议明确结局定义,对发生率和持续时间考虑生存分析,对等级复合结局用非参数检验。

核心结论

  • 为改进ICU谵妄RCT,应明确结局定义,并考虑生存分析方法处理ICU出院或死亡导致的删失。
  • 对等级谵妄复合结局推荐使用非参数检验。

研究设计与样本

  • 系统综述,检索PubMed和Embase,无语言或发表时间限制,检索日期2019年7月8日。
  • 纳入65项以成人ICU患者谵妄为主要结局且结果可获得的RCT。
  • 数据由两人独立提取,综述注册于PROSPERO(CRD42020141204)。

主要发现

  • 65项RCT中44项(68%)针对谵妄预防。
  • 31项(48%)随访≤7天,仅24项(37%)在ICU出院后评估谵妄。
  • 谵妄发生率为最常见结局(50项RCT,77%),应用了8种不同统计方法。
  • 56个谵妄发生率结局中51个(91%)使用两样本检验比较曾发生谵妄的患者比例。
  • 24项RCT评估谵妄持续时间,其中21个(88%)结局使用非参数检验或两样本t检验。

关键数值与推荐

  • 谵妄发生率最常用方法为两样本检验比较曾发生谵妄的患者比例(51/56,91%)。
  • 谵妄持续时间结局中21/24(88%)使用非参数检验或两样本t检验。
  • 复合结局(如基于等级的谵妄和无昏迷天数)用于11项(17%)RCT,其中13个复合结局中11个(85%)使用非参数检验。

临床怎么用

  • 设计ICU谵妄RCT时应预先明确定义谵妄结局及其评估频率和持续时间。
  • 分析谵妄发生率和持续时间时,应考虑因ICU出院或死亡导致的删失,并考虑生存分析方法。
  • 对基于等级的谵妄复合结局,推荐使用非参数检验。

局限性

  • 仅纳入结果可获得的RCT,可能引入选择偏倚。
  • 检索截止于2019年7月8日,未涵盖此后发表的试验。
  • 未报告对纳入研究偏倚风险的评估结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a growing number of randomized controlled trials (RCTs) evaluating interventions to prevent or treat delirium in the intensive care unit (ICU). Efforts to improve the conduct of delirium RCTs are underway, but none address issues related to statistical analysis. The purpose of this review is to evaluate heterogeneity in the design and analysis of delirium outcomes and advance methodological recommendations for delirium RCTs in the ICU. METHODS: Relevant databases, including PubMed and Embase, were searched with no restrictions on language or publication date; the search was conducted on July 8, 2019. RCTs conducted on adult ICU patients with delirium as the primary outcome were included where trial results were available. Data on frequency and duration of delirium assessments, delirium outcome definitions, and statistical methods were independently extracted in duplicate. The review was registered with PROSPERO (CRD42020141204). RESULTS: Among 65 eligible RCTs, 44 (68%) targeted the prevention of delirium. The duration of follow-up varied, with 31 (48%) RCTs having ≤7 days of follow-up, and only 24 (37%) conducting delirium assessments after ICU discharge. The incidence of delirium was the most common outcome (50 RCTs, 77%) for which 8 unique statistical methods were applied. The most common method, applied to 51 of 56 (91%) delirium incidence outcomes, was the two-sample test comparing the proportion of patients who ever experienced delirium. In the presence of censoring of patients at ICU discharge or death, this test may be misleading. The impact of censoring was also not considered in most analyses of the duration of delirium, as evaluated in 24 RCTs, with 21 (88%) delirium duration outcomes analyzed using a non-parametric test or two-sample t test. Composite outcomes (e.g., rank-based delirium- and coma-free days), used in 11 (17%) RCTs, seldom explicitly defined how ICU discharge, and death were incorporated into the definition and were analyzed using non-parametric tests (11 of 13 (85%) composite outcomes). CONCLUSIONS: To improve delirium RCTs, outcomes should be explicitly defined. To account for censoring due to ICU discharge or death, survival analysis methods should be considered for delirium incidence and duration outcomes; non-parametric tests are recommended for rank-based delirium composite outcomes. TRIAL REGISTRATION: PROSPERO CRD42020141204 . Registration date: 7/3/2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Colantuoni E, Koneru M, Akhlaghi N, et al. Heterogeneity in design and analysis of ICU delirium randomized trials: a systematic review. Trials. 2021. PMID: 34016134. doi:10.1186/s13063-021-05299-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。